We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Letter Blasts Sri Krishna Over Data Integrity Concerns
FDA Letter Blasts Sri Krishna Over Data Integrity Concerns
A second FDA inspection of niche drugmaker Sri Krishna after almost 10 years has turned up a bevy of complaints regarding the company’s quality control systems and the accuracy of its data.